SNOA - ABVC SNOA and TISI among pre market gainers

Adagio Therapeutics (ADGI) +64% as COVID drug ADG20 meets main goals in trial; EUA filing in Q2. Vyant Bio (VYNT) +29% on FY results. Sonoma Pharmaceuticals (SNOA) +24% launches new urinary tract infection product through distributors in New Zealand, Australia and South Africa. Vir Biotechnology (VIR) +12% moves up on index change. LightInTheBox Holding (LITB) +11% on Q4 results. Creatd (CRTD) +9%. Team (TISI) +8%. BioNTech (BNTX) +7% Q4 profit soars on COVID vaccine sales; plans buyback, special dividend. Romeo Power (RMO) +7% begins shipment of first pedigree packs to key customer. ABVC BioPharma (ABVC) +7%. Lululemon Athletica (LULU) +7% on Q4 results. Inspirato (ISPO) +6%. Zhangmen Education (ZME) +6% on Q4 results. Lilium (LILM) +5%. American Rebel Holdings (AREB) +5%.

For further details see:

ABVC, SNOA and TISI among pre market gainers